Futura Medical plc
FUM.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.62 | -1.84 | -2.30 | -0.25 |
| FCF Yield | -1.35% | -1.22% | -4.43% | -4.03% |
| EV / EBITDA | 63.02 | -10.12 | -20.91 | -16.45 |
| Quality | ||||
| ROIC | 12.08% | -120.16% | -123.88% | -50.98% |
| Gross Margin | 68.70% | 57.22% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.34 | -0.08 | 0.84 | 0.66 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | -100.00% |
| Free Cash Flow Growth | -37.73% | 85.64% | -51.78% | 5.68% |
| Safety | ||||
| Net Debt / EBITDA | -4.67 | 1.13 | 0.59 | 1.77 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 9.29 | 3,913.70 | 0.00 | 0.00 |
| Cash Conversion Cycle | -25.19 | -141.59 | -4,665.89 | -18,084.01 |